Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial

Evolution of the Randomized Clinical Trial in the Era of Precision Oncology

(2021) Joseph C. Del Paggio et al.   JAMA Oncology

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon

(2020) Patriek Jurrius et al.   BREAST

Does adjuvant therapy reduce post-metastatic survival?

(2019) M K Fink   ANNALS OF ONCOLOGY

Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis

(2016) Giovanni Brandi   WORLD JOURNAL OF GASTROENTEROLOGY

Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis

(2015) Raphael L. C. Araujo et al.   ANNALS OF SURGICAL ONCOLOGY

Peri-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis

(2015) Z.-M. Wang et al.   EJSO

Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome

(2015) Na Yeon Han et al.   RADIOLOGY

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

(2013) Bernard Nordlinger et al.   LANCET ONCOLOGY

A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery

(2011) Toru Beppu et al.   Journal of Hepato-Biliary-Pancreatic Sciences

The management of resectable and unresectable liver metastases from colorectal cancer

(2010) Nancy Kemeny   CURRENT OPINION IN ONCOLOGY

A Randomized Phase II/III Trial Comparing Hepatectomy Followed by mFOLFOX6 with Hepatectomy Alone as Treatment for Liver Metastasis from Colorectal Cancer: Japan Clinical Oncology Group Study JCOG0603

(2009) Y. Kanemitsu et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET